Who has invested in Verge Genomics?

BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator are named among the investors backing Verge Genomics.

Verge Genomics Funding: $180M Raised, Seed

Verge Genomics funding overview

Verge Genomics is a Biotech company based in San Francisco, California. Verge Genomics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed. Investors on record include BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator. 5 distinct backers are named across the disclosed rounds.

Verge Genomics at a glance

Total raised: $180M
Latest round: Seed
Industry: Biotech
Headquarters: San Francisco, California
Notable investors: BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator

Frequently asked about Verge Genomics funding

How much has Verge Genomics raised?: Verge Genomics has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Verge Genomics?: BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator are named among the investors backing Verge Genomics.
What was the latest Verge Genomics funding round?: The most recent disclosed round is a Seed.
Where is Verge Genomics based?: Verge Genomics is based in San Francisco, California.
What sector does Verge Genomics operate in?: Verge Genomics is tracked under Biotech from San Francisco, California, with $180M in disclosed funding.

Verge Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.

Verge Genomics Funding: $180M Raised, Seed

Verge Genomics funding overview

Verge Genomics at a glance

Frequently asked about Verge Genomics funding

Companies related to Verge Genomics (40)

Browse related funding lists (6)